Order Article Reprints

Joseph A, Nyambura CW, Bondurant D, Corry K, Beebout D, Wood TR, Pfaendtner J, Nance E. Formulation and Efficacy of Catalase-Loaded Nanoparticles for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy. Pharmaceutics. 2021; 13(8):1131. https://doi.org/10.3390/pharmaceutics13081131

Joseph, Andrea, Chris W. Nyambura, Danielle Bondurant, Kylie Corry, Denise Beebout, Thomas R. Wood, Jim Pfaendtner, and Elizabeth Nance. 2021. "Formulation and Efficacy of Catalase-Loaded Nanoparticles for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy" Pharmaceutics 13, no. 8: 1131. https://doi.org/10.3390/pharmaceutics13081131

Joseph, A., Nyambura, C. W., Bondurant, D., Corry, K., Beebout, D., Wood, T. R., Pfaendtner, J., & Nance, E. (2021). Formulation and Efficacy of Catalase-Loaded Nanoparticles for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy. Pharmaceutics, 13(8), 1131. https://doi.org/10.3390/pharmaceutics13081131